These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13759758)

  • 1. [Relations between the action of pyrimidine stimulators and inhibitors of cell growth and proliferation].
    LAZAREV NV; FELISTOVICH GI
    Vopr Onkol; 1961; 7(8)():65-72. PubMed ID: 13759758
    [No Abstract]   [Full Text] [Related]  

  • 2. OETTGEN HF, REPPERT JA, COLEY V: Studies on the synergism of fluorinated pyrimidines and certain pyrimidine and purine derivatives against transplanted mouse leukemia.
    BURCHENAL JH
    Cancer Chemother Rep; 1960 Feb; 6():1-5. PubMed ID: 13806003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the cell division inhibitory effect of some purine and pyrimidine derivatives on Paracentrotus lividus and on sarcoma 180 of mice].
    Ballweg H; Schmähl D; von Wedelstaedt E
    Arzneimittelforschung; 1969 Aug; 19(8):1296-8. PubMed ID: 5820296
    [No Abstract]   [Full Text] [Related]  

  • 4. Derivatives of 2,4-diaminopyrimidine as growth inhibitors.
    MODEST EJ; FOLEY GE; FARBER S
    Acta Unio Int Contra Cancrum; 1960; 16():702-8. PubMed ID: 14423146
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antiproliferative evaluation of novel N-alkylated 6-isobutyl- and propyl pyrimidine derivatives.
    Gazivoda Kraljević T; Ilić N; Stepanić V; Sappe L; Petranović J; Kraljević Pavelić S; Raić-Malić S
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2913-7. PubMed ID: 24835982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of aurora kinases inhibitors based on N-trisubstituted pyrimidine scaffold.
    Long L; Luo Y; Hou ZJ; Ma HJ; Long ZJ; Tu ZC; Huang LJ; Liu Q; Lu G
    Eur J Med Chem; 2018 Feb; 145():805-812. PubMed ID: 29358147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Lin R; Johnson SG; Connolly PJ; Wetter SK; Binnun E; Hughes TV; Murray WV; Pandey NB; Moreno-Mazza SJ; Adams M; Fuentes-Pesquera AR; Middleton SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2333-7. PubMed ID: 19286381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiproliferative activity of imidazo[1,2-a]pyrimidine Mannich bases.
    Aeluri R; Alla M; Polepalli S; Jain N
    Eur J Med Chem; 2015 Jul; 100():18-23. PubMed ID: 26067381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia.
    Kim H; Lee C; Yang JS; Choi S; Park CH; Kang JS; Oh SJ; Yun J; Kim MH; Han G
    Eur J Med Chem; 2016 Sep; 120():74-85. PubMed ID: 27187860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and pharmacological evaluation of N4,N6-disubstituted pyrimidine-4,6-diamine derivatives as potent EGFR inhibitors in non-small cell lung cancer.
    Zhang Y; Lv H; Luo L; Xu Y; Pan Y; Wang Y; Lin H; Xiong J; Guo P; Zhang J; Li X; Ye F
    Eur J Med Chem; 2018 Sep; 157():1300-1325. PubMed ID: 30195240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and preclinical evaluation of NRC-AN-019.
    Amala K; Bhujanga Rao AK; Gorantla B; Gondi CS; Rao JS
    Int J Oncol; 2013 Jan; 42(1):168-78. PubMed ID: 23151973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents.
    Yang JS; Park CH; Lee C; Kim H; Oh C; Choi Y; Kang JS; Yun J; Jeong JH; Kim MH; Han G
    Eur J Med Chem; 2014 Oct; 85():399-407. PubMed ID: 25108079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and structure-activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitors.
    Pecchi S; Renhowe PA; Taylor C; Kaufman S; Merritt H; Wiesmann M; Shoemaker KR; Knapp MS; Ornelas E; Hendrickson TF; Fantl W; Voliva CF
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6895-8. PubMed ID: 21035331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines.
    Manetti F; Brullo C; Magnani M; Mosci F; Chelli B; Crespan E; Schenone S; Naldini A; Bruno O; Trincavelli ML; Maga G; Carraro F; Martini C; Bondavalli F; Botta M
    J Med Chem; 2008 Mar; 51(5):1252-9. PubMed ID: 18257513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
    Zhang P; Dong J; Zhong B; Zhang D; Yuan H; Jin C; Xu X; Li H; Zhou Y; Liang Z; Ji M; Xu T; Song G; Zhang L; Chen G; Meng X; Sun D; Shih J; Zhang R; Hou G; Wang C; Jin Y; Yang Q
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1910-8. PubMed ID: 26979157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
    Ibrahim DA; El-Metwally AM
    Eur J Med Chem; 2010 Mar; 45(3):1158-66. PubMed ID: 20045222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeno[1,2-d]pyrido[1,2-a]pyrimidines: a new class of receptor tyrosine kinase inhibitors.
    Tsanakopoulou M; Cottin T; Büttner A; Sarli V; Malamidou-Xenikaki E; Spyroudis S; Giannis A
    ChemMedChem; 2008 Mar; 3(3):429-33. PubMed ID: 18181120
    [No Abstract]   [Full Text] [Related]  

  • 19. AURKA inhibitors: right in time.
    Kovar H
    Pediatr Blood Cancer; 2010 Jul; 55(1):3-4. PubMed ID: 20486161
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.